Concepedia
Statistics
Publications
13
Citations
616
H-Index
11
Active since
1995
Affiliations
Pfizer (United States)(Current)
The University of Texas MD Anderson Cancer Center
Moffitt Cancer Center
Wayne State University
Texas Oncology
Irene Eiseman is an author at Pfizer (United States) specializing in medicine, cancer therapeutics, and oncology.
Top concepts
MedicineOncologyPharmacologyCancer TherapyAntibioticsLung CancerInfection ControlRadiation OncologyClinical MicrobiologyAntimicrobial Resistance
Publications per year
1995–2007
Multicenter, Randomized, Phase II Trial of CI-1033, an Irreversible Pan-ERBB Inhibitor, for Previously Treated Advanced Non–Small-Cell Lung Cancer
Pasi A. Jänne, Joachim von Pawel, Roger B. Cohen et al. · Journal of Clinical Oncology · 2007 · 118 citations · Full text
Potential benefits of the irreversible pan-erbB inhibitor, CI-1033, in the treatment of breast cancer
Lee F. Allen, P Lenehan, Irene Eiseman et al. · Seminars in Oncology · 2002 · 104 citations
Breast Oncology, Potential Benefits, Medicine +7
Phase 1 Clinical and Pharmacokinetics Evaluation of Oral CI-1033 in Patients with Refractory Cancer
John Nemunaitis, Irene Eiseman, Casey Cunningham et al. · Clinical Cancer Research · 2005 · 86 citations · Full text
Administration of CI-1033, an Irreversible Pan-erbB Tyrosine Kinase Inhibitor, Is Feasible on a 7-Day On, 7-Day Off Schedule
Emiliano Calvo, Anthony W. Tolcher, Lisa A. Hammond et al. · Clinical Cancer Research · 2004 · 81 citations
Clinafloxacin versus Piperacillin-Tazobactam in Treatment of Patients with Severe Skin and Soft Tissue Infections
Ghodrat A. Siami, N. V. Christou, Irene Eiseman et al. · Antimicrobial Agents and Chemotherapy · 2001 · 71 citations · Full text
1–5 of 13